Evox Therapeutics procures $45.4 mln Series B
UK-based Evox Therapeutics Ltd, an exosome therapeutics company, has raised $45.4 million in Series B financing. Redmile Group led the round with participation from other investors that included GV, Cowen Healthcare Investments, Panacea Healthcare Venture, Borealis Ventures, Oxford Sciences Innovation and Oxford University.
4 September 2018•1 min read
